Pegylated Liposomal Doxorubicin: A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma

By Duggan Sean T.   Keating Gillian M.  

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2531-2558

Adis International

Access to resources Recommend Favorite

Biweekly paclitaxel plus gemcitabine is a highly active and well tolerated regimen in women with advanced breast cancer

By  

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Doxorubicin liposomal + docetaxel: efficacy in metastatic breast cancer?

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Docetaxel plus cisplatin: active and well tolerated in locally advanced or metastatic gastric cancer

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Edatrexate [10 EDAM] shows relatively moderate activity in the treatment of metastatic breast cancer, but is well tolerated

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite